Skip to main content

BRS3 → BRS1 — Inflammatory Modulation of Neurotransmitter Systems

This page explains the systems-level biological dependency between BRS3 and BRS1. It is informed by literature, integrated BRS architecture, allostatic context, expert interpretation, and mechanistic evidence from PM pages — but it does not duplicate the canonical PM relationship graph.

For explicit PM-to-PM relationships, see §6.2 Cross-BRS Mechanism Relationships on individual Primary Mechanism pages.

Biological Contribution​

Collectively, the Functional Mechanisms within BRS3 maintain the adaptive inflammatory and redox resilience required to preserve an immune environment that supports resilient neurotransmitter regulation within BRS1 during prolonged physiological demand.

Systems Significance​

By preserving these immune-regulatory capacities, BRS3 functions as an upstream enabling system, reducing the likelihood that inflammatory and oxidative burden progressively constrain neurotransmitter regulation within BRS1 as allostatic load accumulates. Maintaining BRS3 therefore complements neurotransmitter precursor and cofactor biology by preserving the biological environment within which resilient neurotransmitter regulation can be sustained, rather than substituting for neurotransmitter regulation itself.

Integrated Regulatory Capacity​

Together, the Functional Mechanisms within BRS3 maintain proportionate inflammatory signalling, antioxidant defence, oxidative resilience and active inflammation resolution required to preserve immune and redox stability during prolonged physiological demand. Rather than acting through a single inflammatory pathway, these integrated capacities collectively regulate how immune and oxidative load influences the biological environment within which BRS1 sustains neurotransmitter regulation.

Supporting Evidence​

  • Slavich & Irwin, 2014 — Established that psychological and physiological stressors activate inflammatory signalling capable of reshaping central nervous system function through coordinated immune, neuroendocrine and neurochemical pathways. This supports the framework interpretation that chronic inflammatory activation can become a principal upstream constraint on BRS1 performance during sustained physiological demand.
  • Savitz, 2019 — Demonstrated that immune activation reshapes neurotransmitter regulation through the kynurenine pathway and broader neuroimmune interactions, influencing both monoaminergic signalling and excitation–inhibition balance. This supports the BRAIN Framework interpretation that maintaining immune regulation preserves the biological environment required for resilient monoaminergic and excitation–inhibition regulation within BRS1.